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Objectives. This study was conducted to quantify the variability
of ° ST segment depression in chronic stable a
and
enable assessment of the impact of interventions in individual
patients and clinical trials
.
Background. Episodic myocardial ischemia can be detected by
ST segment depression on ambulatory electr ardiographic
(ECG)
monitor'
and may be important for the assessment of
outcome
. Variability of the number and duration of episodes has
important implications for monitoring and therapeutic strategies
.
Methods. We studied 36 patients, aged 37 to 77 years (median
60), with stable angina and coronary artery d' by serial
ambulatory ECG monitoring for a total of 415 days. A nested
analysis of v was carried out to assess the
sources of
spontaneous variation, and power function analyses were per-
formed .
Results . During 415 days of monitoring, , 2 episodes of ST
It is now appreciated that the activity of transient myocardial
ischemia in patients with coronary artery disease is signifi-
cantly underestimated by symptoms (1-3) . Ambulatory ST
segment monitoring provides an objective measure of the
total number and duration of symptomatic and "silent"
ischemic episodes (4,5) and allows the study of patients
during their normal daily activities (6) . In this setting, ST
depression has been shown by both imaging and hemody-
namic studies (7-9) to reflect myocardial ischemia and has
been related to morbidity and mortality in patients with
stable (10,11) and unstable (12) angina and after myocardial
infarction (13). Studies (14-17) have examined the impact of
a variety of interventions on the frequency and duration of
ischemic episodes during normal daily life using ambulatory
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segment depression were detected (mean frequency ± SD, 4 .5 ±
4.1/day, duration 67 ± 87 min/day, 25% in association with pain) .
Considerable variability was found within and between patients
for both the number and the duration of ischemic episodes . For a
patient monitored for 24 h before and after treatment, an 81%
reduction in the number of episodes would be required to show a
significant benefit ; if monitoring were performed for 4 days four
times before and after therapy, a 46% decrease would be signif.
icant. In c. .e,ical trials, a true reduction of ?15% in ischemic
episodes is required to have sufficient power to obtain statistical
signi nce.
Conclusions. The natural variability of transient myocardial
ischemia in patients with chronic stable angina can be quantified
and this information used to study the effectiveness of interven-
tions in both individual patients and clinical trials .
(J A m Coll Cardiol 1994923 .66-73)
electrocardiographic (ECG) monitoring ; however, there is
considerable natural variability in these end points . This
complicates the use of ambulatory ECG monitoring in as-
sessing responses to therapy in both individual patients and
clinical trials .
Two previous studies (18,19) have examined the natural
variability of ischemic episodes in patients with coronary
artery disease and stable angina and described significant
between-patient and within-patient sources of variability .
These studies examined relatively few days of monitoring
and did not provide data to allow for a parallel group trial
design, which is relevant for large clinical trials of morbidity
and mortality (20) . Using a larger number of monitored days,
we examined and quantified the natural variability in ambu-
latory ischemia in patients with chronic stable angina and
used this information to allow both rational design of clinical
trials and assessment of treatment response in individual
patients with coronary artery disease .
Methods
Subjects. Thirty-six consecutive outpatients who fulfilled
the following eligibility criteria were included in the study :
typical angina pectoris, occurring five or more times/week
0735-10971941$6.00
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without appreciable change in symptoms during the previous
6 months, and a positive exercise test using conventional
criteria for ST segment depression (21) . No patient had ECG
evidence of conduction defects, atrial fibrillation, valvular
heart disease, ventricular hypertrophy or other conditions
known to influence the ST segment . None were receiving
digoxin. In all patients, reversible abnormalities of regional
myocardial perfusion during ST segment depression were
demonstrated by measurement of regional myocardial up-
take of rubidium-82 and positron emission tomography (7) .
Written informed consent was obtained from each patient
before the first period of ambulatory monitoring . The study
was approved by the local committee on ethical practice .
Protocol . Each patient underwent 4 consecutive days of
outpatient ambulatory ECG monitoring for ST segment
analysis . Over the next 18 months, a further zero to seven
periods of monitoring per patient were performed, each
consisting of 2 to 4 days of recording at variable intervals of
l to 12 weeks . All antianginal medications were gradually
withdrawn before periods of ECG monitoring so that only
sublingual nitroglycerin as needed was taken for 48 h before
and during each period of monitoring. Patients were asked to
perform their normal daily activities, and a written struc-
tured diary was used to record episodes of angina, nitroglyc-
erin consumption and patient activity . Patients were also
requested to press an event button on the recorder if they
experienced symptoms .
Ambulatory monitoring. Recordings were obtained us-
ing calibrated two-channel Oxford Medilog 2 frequency-
modulated recorders . Two bipolar leads were monitored,
one precordial lead corresponding to the position of maximal
ST segment depression during exercise testing (almost al-
ways equivalent to a CM5 lead) and one modified inferior
lead. Electrode positions for each patient were not altered
throughout the study . The recorders were calibrated with
standard 1-mV signals . Control recordings were made in the
supine, prone, sitting and standing positions to ensure that
significant ST segment depression did not occur with pos-
tural change .
Recorders were analyzed at 60 times real time with an
Oxford Medilog MA20 analyzer . Baseline tracings were
obtained as reference, and visual analysis was performed by
a single experienced physician who did not know the pa-
tient's identity . Episodes of ST segment depression were
identified and printed if they met the following criteria :
planar or downsloping ST depression lasting >80 ms after
the J point for L-I min in one or both leads . The visual
analysis was checked against a strip chart printout of heart
rate and ST position and validated against a computer
program in 50 records . Once an episode was identified, strips
of the ECG were printed for the time at the onset of ST
depression, maximal ST depression (rounded to the nearest
millimeter for each episode) and the return to baseline . For
each episode, the time of onset and offset, duration (from
onset to return to baseline [in minutes]), presence or absence
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Figure 1 . Variability of ST segment depression over 4 consecutive
days of ambulatory electrocardiographic monitoring, showing that
the mean and standard deviation for the number of episodes are
related (that is, more episodes are associated with more variability)
.
of pain and heart rate at the onset of ST depression were
recorded .
Statistics . For each 24-h record, the total number of
episodes of ST segment depression, the number accompa-
nied by chest pain, the total duration of ST depression and
the total duration of episodes accompanied by pain were
calculated . Episodes of ST depression L-2 mm were then
analyzed separately (that is, excluding all episodes of 1-mm
depression) in the same manner .
After the initial 4 days of monitoring, follow-up monitor-
ing was undertaken at approximately 2 months (32 patients),
6 months (8 patients), 12 months (17 patients) and 18 months
(6 patients) ; 18 further monitoring occasions lay outside
these intervals . Each day of monitoring provided a count of
ischernic episodes and their combined length, and each was
classified by the presence or absence of pain and whether or
not the ST segment depression was 2:2 mm. The extent of
spontaneous variation was summarized by calculating the
mean ± SD of each outcome measure within each monitor-
ing occasion . A plot of mean values ± SD (Fig . 1) reveals the
need for transformation to achieve approximately similar
variation within each occasion, and following previous anal-
yses a logarithmic transformation log (x + 1) was adopted .
This had the additional benefit of expressing hypothesized
benefits from treatment as proportional reductions in isch-
emia. A five-level nested analysis of variance was then
carried out to determine the relative magnitude of the
different sources of spontaneous variation . The five levels
were: between patients, between 4-month periods (within
patients), between months (within 4-month periods), be-
tween weeks (within months) and between days (within
weeks) .
These results allow an estimate of the percent reduction
in ischernia that would have to be observed in an individual
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Table 1
. Sources of Variability* in ST Segment Monitoring
'In each of the six columns, the sources of variability are expressed as the calculated variance due to each component, followed (in parentheses) by the
percent that this component contributes to the total variability
. Variability data are presented for both the number and duration of episodes, considering painful,
?2 mm ST segment depression and total episodes separately
. }Within p atients . t p
< 0.05. 1 ST = ST depression .
patient in order to be confident that the change was not
simply due to spontaneous variation . It was then assumed
that investigators would wish to design studies with 80%
statistical power and a confidence level where p = 0 .05
(two-sided test) . The number of patients required to detect a
range of hypothesized benefits could then be calculated for
various study designs using the results from the analysis of
variance (technical details are provided in the Appendix) .
Results were calculated for crossover and parallel group trial
designs for different strategies of monitoring frequency and
duration.
Results
Patient characteristics . The 27 men and 9 women were
aged 37 to 77 years (median 60) . All had angina induced by
exercise, and 15 also had angina during other stresses (cold,
smoking, mental stress, postprandial) . The historical dura-
tion of angina ranged from 2 to 16 years (median 4), with a
wide range in frequency from < I to 6 attacks/day (median 2) .
Twelve patients had a history and ECG evidence of prior
myocardial infarction (inferior in eight, anterior in four) ? I
year before study . Coronary arteriography had been per-
formed in 33 patients (91%) and demonstrated >70% diam-
eter narrowing in three vessels in 16 patients (44%), two
vessels in 15 patients (42%) and one vessel in two patients
(6%). Three patients were not studied by angiography either
because of their age (>70 years, n = 2) or because they were
unwilling to undergo the procedure (n = 1) .
Coronary artery bypass graft surgery had b,~en performed
in six patients before the study, and all had subsequently
redeveloped stable angina and evidence of myocardial isch-
emia on exercise testing and positron emission tomography .
During the study, one patient sustained an acute myocardial
infarction and one died suddenly at home, both while taking
their normal medical therapy. Neither had had a prior
change in angina frequency . No other patients required
hospital admission for a change in clinical status or interven-
tion during the study period .
Ambulatory electrocardiographic monitoring . The 36 pa-
tients underwent a total of 415 days of recording (4 to 28
dayslpatient, median 12), giving a total of 9,960 h of moni-
toring, during which 1,882 episodes of ST segment depres-
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lion were identified. Four hundred sixty-five (25%) of the
episodes of ST depression were accompanied by angina . The
mean number of episodes/24 h was 4 .5 ± 4.1 (range 0 to 23),
with no episodes occurring in 72 of the 24-h periods . The
duration of ST segment depression ranged from 0 to 793
min/day, with a mean duration of 67 ± 87 min/24-h record .
There were 1,036 episodes of ST depression >2 mm (mean
number 2.5 ± 3.4/24 h, mean duration 42 ± 78 min/24 h) .
Components of variability . The sources of variability in
ST segment monitoring (between patients, within patients-
between 4 months, between months, between weeks and
between days) are shown in Table I for the total number and
total duration of all episodes . The greatest sources of vari-
ability were between patients and between days within
patients for all end points . An additional source of variation
was between weeks, but no additional variability was found
between months for any end point . There was some evidence
of longer-term variability . Similar results were obtained when
components of variability were analyzed by considering only
episodes of ST depression >2 mm or when only episodes
accompanied by angina were analyzed (Table 1) .
Individual variability . Even though the clinical status of
the patients was stable, there was significant within-patient
variability in the number and duration of episodes of ST
segment depression. An example of the day to day variabil-
ity in ischemic episodes for two patients is shown in Figure
2. Different patterns of ischemic variability are demon-
strated, with a decrease in the number of episodes in one
patient and an increase in the other . Tables 2 and 3 show the
observed percent reductions required in the number and
duration of ischemic episodes to reach statistical significance
(two-sided, 5% level) to show that an individual patient has
less ischemia after an intervention than before and that this
is not merely due to naturally occurring variation . For
example, for a single day of monitoring performed before
and after an intervention, an 81% reduction in the number of
ischemic episodes would be required for confidence of a real
effect; however, if monitoring were carried out for 4 days on
four occasions before and after intervention, a reduction of
only 46% would be required .
Variability in patient groups . Crossover protocols .
Figure 3 demonstrates the relation between the hypothesized
percent reduction in the total number (Fig . 3A) and duration
Source of Variation
No . of Episodes
with Pain
No . of Episodes
?2 mm I
ST
Total No. of
Episodes
Duration of Episodes
With Pain
Duration of Episodes
a2 mm 1 ST
Total
Duration
Between patients 0.1403%)
0.29(41%) 0.25 (35%) 0.79(21%) 1 .30(32%) 0.72(23%)
Between 4 monthst 0 .03 (6%)
0.06(8%) 0.10 (t4%)t 0.40 (10%) 0 .35 (9%) 0
.67 (21%)$
Between months 0 (0%) 0070)
0.003 (0%) 0(0%) 00170) 0(070)
Between weeks 0. (17%)
0.13(17%) 0.14 (20%) 0.93(25%) 0 .92(23%) 0.79(25%)
Between days 0 .19(44%)
0.23 (34%) 0.2? (31%) 1 .66(44%) 1 .44 (36%) 1,03(31%)
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Figure 2 . Results of ST segment ambulatory monitoring over 4
consecutive days in two patients with chronic stable angina . Differ-
ent patterns of ischemic activity are shown, with a decrease in
episodes over the 4 days in Patient A and an increase in Patient B .
(Fig. 3B) of episodes of ST segment depression and the
number of patients required for 80% power to obtain a
significant result at the two-sided 5% level . Curves are
drawn to represent this relation for different frequencies and
durations of ambulatory monitoring. For example, in a
crossover trial in which 48-h ambulatory monitoring was
performed before and after an intervention with a hypothe-
sized reduction of 35% in the number of ischemic episodes,
20 patients would be required to have an 80 17, c power of
demonstrating a significant benefit (the middle solid line in
fig. 3A) .
Parallel group studies . Figure 4 illustrates the relation
between the hypothesized percent reduction in the total
number (Fig. 4A) and duration (Fig . 4B) of episodes and the
number of patients required for parallel group studies for
different monitoring protocols. Much larger numbers are
required ; for example, using the same regimen and monitor-
ing strategy as in the crossover protocol (48-h monitoring
before and after an intervention, with a hypothesized 35%
reduction in ischemia), 100 patients would be required to
have the same power as a crossover trial .
Table 2 . Percent Reduction in the Number of Ischemic : Episodes
for Statistical Significance (two-sided, 5% level) in an Individual
Patient for Different Duration and Number of Occasions of
Ambulatory ST Segment Monitoring
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Tattle 3. Percent Reduction in the Duration of ischemic Episodes
for Statistical Significance (two-sided, 5% level) in an Individual
Patient for Different Duration and Number of Occasions of
Ambulatory ST Segment Monitoring
Discussion
The large variability within and between patients in the
number and duration of episodes of ST segment depression
during ambulatory ECG monitoring has important implica-
tions for the use of this technique for stratifying risk and
examining the effect of treatment, both for individual pa-
tients and for groups of patients . The variability between
patients is mainly from day to day and week to week, with
little additional variability demonstrated with longer moni-
toring intervals ; this information is useful for the design of
long-term clinical trials . Although ambulatory ST monitoring
outside the hospital is more variable than the results of
exercise tests (2,18), ischemia in this setting is potentially
more responsive to therapy than are the end points used in
exercise testing (22) .
Confining analysis to episodes of ST depression -=:2 mm
has been proposed as a means of improving the specificity of
the signal as a marker of ischemia and reducing variability,
In this study, the natural variability was not different when
analysis was confined in this way and sensitivity was appre-
ciably decreased, as almost half the episodes of ST depres-
sion are 1 mm. Similarly, the natural variability of painful
episodes was as great as that for episodes without accompa-
nying angina although the patients had the clinical syndrome
of chronic stable angina pectoris .
Both the number and duration of ischemic episodes are
widely used end points in clinical trials of "total ischemic
burden" (14-17) . In this study, the total duration of ST
segment depression was much more variable than the num-
ber of episodes (Table 1) . We measured the duration of
episodes from baseline to baseline, rather than from and to
0.1-mV ST depression (the I x I x I rule) (23) . This
accounts for ti-e relatively long average duration of episodes
in this study . Defining duration of episodes by the I x 1 x I
rule may decrease variability, but at the cost of considerable
underestimation of the true duration of the underlying isch-
emic event (24,25). However it is
measured, the total dura-
tion of ischemia over 24 h is inherenti : , more variable
because it incorporates both the variability in the number of
events and their individual duration .
As noted by Nabel et al
. (19), the analysis of variance
depends on assumptions that are not strictly warranted in
view of the existence of days on which no ischemic episodes
Occasions (before and after intervention)
1 1 4
Days per occasion
1 81% 69% 57%
2 75% 63% 50%
4 71% 58%
46%
Occasions (before and after intervention)
2 4
Days per occasion
I 98% 93% 85%
2 MCI M
4 94% 8617c 70
70
a
C
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3
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Z
7
Z
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Total sample size for CROSSOVER trial, 80°/6 power, p = 0.05
20
20
1 occ . per treat. ; 1,2,4 days per occ.
2 = . per treat.; 1,2
.4 days par ccc .
-- 3 ow . per treat.
; 1,2,4 days per ccc .
40
%
reduction in episodes
40
% reduction in duration
were exhibited . Reanalysis excluding the three patients who
contributed the major proportion of such negative days did
not substantially alter the conclusions . However, although
the power analysis is reasonable for designing trials, it would
seem appropriate to adopt more sophisticated techniques for
the final analysis of the trial results
. Such techniques might
involve the use of generalized linear models for data mea-
I
60
Total sample size for CROSSOVER trial, 80°/® power, p = 0.05
60
sured as counts ("Poisson regression"), which are now
available in statistical packages (26) .
Studies on individual patients. The circadian variation in
ischemic activity (27,28) means that for practical purposes
24 h is the minimal duration of ambulatory ECG monitoring
required for the assessment of any patient . The examples in
Figure 2, however, show the possible hazards of data
1
	
,1 ,1`	'
1 1 1
1 occ • per treat. ;1 .2,4 days par occ•
2 ccc . per treat.; 1,2 .4 days per occ
.
-- 3 =,
per treat.
; 1,2,4 days per occ .
l l
1
1
\ \
l 1
1 S
1 \ ,
\
1
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Figure 3. Power function analysis
(80% power at 95% confidence level)
for crossover trials of interventions for
ST segment depression . A, Number of
episodes . B, Duration/24 h . For each
group of lines, that lying furthest to the
right represents the fewest days of
monitoring per occasion . occ . = occa-
sions', treat . = treatment .
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Figure 4. Power function analysis
0% power at 95% confidence level)
for parallel group trials of interventions
for ST segment depression . A, Number
of episodes. 6, Durationi24 h . Abbre-
viations as in Figure 3,
0 i
01
- I
0
M
0
0
interpretation from 24-h assessment periods only ; a clinician
starting a new drug on day 2 might think that patient A
showed significant improvement and patient B showed de-
terioration, whereas the observations are due to spontane-
ous variabiiity .
Using data from 36 well characterized patients with stable
symptoms monitored over 415 days, we assessed the impli-
0
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Total sample size for PARALLEL trial, 80°/
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V.1:2 4 d
40
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Total sample size for PARALLEL trial, 80% power, p = 0 .05
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2
par treat. : 1,2,4 days per occ .
3
paoraat,
;1 .2
4
days per OCC
40
% reduction in duration
er, p = 0.05
60
60
cations of this variability for individual patient monitoring .
In all of these subjects, ST segment depression had been
proved to reflect myocardial ischernia by positron emission
tomography
. In our study, an 81% reduction in the number
of ischemic episodes would be required to be confident of a
treatment benefit if the patient was monitored for 24 h before
and after the intervention . When Nabel et al
. (19) examined
72
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this issue (using data from 42 patients with stable angina
monitored far 194 days), they found that essentially all
episodes of ischemia had to be eliminated in an individual
patient to be confident of a therapeutic effect, whereas
Nademanee et at. (18) found in a study of 40 patients who
were monitored for 120 days that a reduction of 72% would
be required. We demonstrated that this problem of variabil-
ity for individual patients may be partially circumvented by
increasing the number of days and the number of occasions
of monitoring . However, this improved ability to detect
significant change, is obtained at the cost of a tedious,
time-consuming, expensive and labor-intensive procedure
using current tape-based analysis systems. More recently
developed microprocessor recorders with real time analysis,
multiday recording capability and validated algorithms (29)
may make such long-term monitoring of ischemia a realistic
option for individual patient management .
Ambulatory electrocardiographic monitoring in clinical
trials . The power function analysis presented shows that
the number of patients required is not fixed but depends on
the study design, the extent of monitoring and the efficacy of
the intervention to be studied .
Crossover trials. Ambulatory ECG monitoring is a very
practical technique for studying the effects of interventions
on ischemia when used in a crossover trial design . For
treatments with a ?30% hypothesized reduction in the
number of ischemic episodes, only X20 patients are required
for a practical protocol involving 48 h of monitoring before
and after intervention . There is little benefit in increasing the
duration or frequency of monitoring occasions above this
level. However, it is difficult to demonstrate a treatment
effect with any therapy causing s 15% reduction in the
number of ischemic episodes unless the trial is very large .
Parallel group trials . This design is commonly used for
trials involving nondrug interventions, such as coronary artery
bypass grafting or angioplasty . A large multicenter interna-
tional trial examining the impact of medical and revasculariza-
tion procedures on myocardial ischemia using ambulatory
ECG monitoring (the Asymptomatic Cardiac Ischemia Pilot
Study [201) is underway, and data allowing appropriate plan-
ning of such studies have not been previously reported . Such
trials must take into account the significant component of
between-patient as well as within-patient variability . As a
result, for a given treatment benefit, patient numbers will
invariably need to be larger than for crossover trials . it is still
impractical to assess relatively weak interventions with :515%
hypothesized reduction in ischemic events, whatever monitor-
ing protocol is used . For most clinically relevant interventions
where =20% reduction in ischemic episodes might be sought .
one period of 48-h monitoring before and after an intervention
is usually appropriate .
Conclusions . In patients with coronary artery disease,
ischemic activity can be assessed objectively by using am-
bulatory ST segment monitoring during normal daily life.
Because this finding relates to prognosis, it is appropriate to
test the effect of therapies on this measure of ischemia. The
We thank Mary Jane Potter for expert secretarial assistance .
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important component of natural variability in ischemia as
measured by this sampling method can be quantified so that
ambulatory ECG monitoring can be used in a rational
manner to study interventions in individual patients and
clinical (rials .
Appendix
Basis for Calculations
Let T be the statistic that will be used to estimate the mean
difference in response after logarithmic transformation between
control and treatment periods, and V,1( be the variance of T, where
I is the total number of patients in the study . Let V,, denote the
between patient variance, V,, denote the between week, within
patient variance and V,, denote the between day, within week,
within patient variance ; !,,, V,,. . V,, are all estimated in Table 1 .
When a single patient is measured for J weeks on K days a week,
the mean response will have variance W = V„lJ + V,/JK. In a
crossover trial, assuming no carryover and no treatment period
interaction,
V,ll
= 2W/1. In a parallel study with 112 patients per
group monitored for J weeks on K days a week, the overall mean
difference between treatment and control has variance Vrl1= 4(W +
V,,)11
.
Suppose we hypothesize a reduction due to treatment of
t%1%.
On
a logarithmic scale, this is equivalent to a treatment effect of d =
-logll - r/100) . Thus, if the hypothesized reduction truly holds, our
test statistic T should have mean d and variance
V(T)Il,
and the
number of patients in the study to have 80% power to correctly
reject the hypothesis of no effect with a two-sided test at the 5%
level is given by :
I = 10 .842+1 .94i)2V1 1d-
Plotting 1 against r provides Figures 3 and 4
.
Consider a single patient measured over J weeks on K days
before and after treatment . From random variation alone, there is a
5% chance the apparent response will exhibit a change
of at lease
td = I.96V2W. Translating back from a logarithmic scale by r =
100(1 - e-")% provides the entries in Tables 2 and 3 for the percent
reduction that might be expected by chance .
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